Search Results

LFM-A13 100 mg  | 99.90%

TargetMol

LFM-A13（IC50=2.5 μM）, a specific Bruton’s tyrosine kinase (BTK), is more than 100-fold specificity than other protein kinases, such as JAK1, JAK2, HCK, EGFR, and IRK.

More Information Supplier Page

Abiraterone 200 mg  | 99.87%

TargetMol

Abiraterone (CB-7598) is an effective steroidal cytochrome P450 17alpha-hydroxylase-17, 20-lyase (CYP17) inhibitor (IC50: 4 nM).

More Information Supplier Page

Abiraterone 25 mg  | 99.87%

TargetMol

Abiraterone (CB-7598) is an effective steroidal cytochrome P450 17alpha-hydroxylase-17, 20-lyase (CYP17) inhibitor (IC50: 4 nM).

More Information Supplier Page

Astragaloside A 100 mg  | 99.87%

TargetMol

Astragaloside A (Astragaloside IV) is the primary pure saponin isolated from Astragalus membranaceus, which has been widely used for the therapy of cardiovascular diseases.

More Information Supplier Page

Astragaloside A 200 mg  | 99.87%

TargetMol

Astragaloside A (Astragaloside IV) is the primary pure saponin isolated from Astragalus membranaceus, which has been widely used for the therapy of cardiovascular diseases.

More Information Supplier Page

Butein 25 mg  | 98.76%

TargetMol

Butein, a plant polyphenol, is isolated from Rhus verniciflua. It can inhibit the activation of protein tyrosine kinase, NF-κB and STAT3, and also can inhibit EGFR.

More Information Supplier Page